Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

lupus nephritis

  • You have accessRestricted Access
    Will New Treatment Options for Lupus Nephritis Be Affordable?
    Y.K. Onno Teng and Ton J. Rabelink
    CJASN March 2022, 17 (3) 340-341; DOI: https://doi.org/10.2215/CJN.00690122
    Add to Selected Citations
  • The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
    You have accessRestricted Access
    The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
    Olena Mandrik, James Fotheringham, Shijie Ren, Jeffrey A. Tice, Richard H. Chapman, Matthew D. Stevenson, Steven D. Pearson, Serina Herron-Smith, Foluso Agboola and Praveen Thokala
    CJASN March 2022, 17 (3) 385-394; DOI: https://doi.org/10.2215/CJN.13030921
    Add to Selected Citations
  • You have accessRestricted Access
    The Use of Serological Tests in the Care of Patients with Lupus Nephritis
    Isabelle Ayoub and Brad H. Rovin
    CJASN February 2022, 17 (2) 305-307; DOI: https://doi.org/10.2215/CJN.13431021
    Add to Selected Citations
  • Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis
    You have accessRestricted Access
    Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis
    Scott E. Wenderfer, Joyce C. Chang, Amy Goodwin Davies, Ingrid Y. Luna, Rebecca Scobell, Cora Sears, Bliss Magella, Mark Mitsnefes, Brian R. Stotter, Vikas R. Dharnidharka, Katherine D. Nowicki, Bradley P. Dixon, Megan Kelton, Joseph T. Flynn, Caroline Gluck, Mahmoud Kallash, William E. Smoyer, Andrea Knight, Sangeeta Sule, Hanieh Razzaghi, L. Charles Bailey, Susan L. Furth, Christopher B. Forrest, Michelle R. Denburg and Meredith A. Atkinson
    CJASN January 2022, 17 (1) 65-74; DOI: https://doi.org/10.2215/CJN.07810621
    Add to Selected Citations
  • You have accessRestricted Access
    When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis
    Gabriella Moroni, Giulia Frontini and Claudio Ponticelli
    CJASN December 2021, 16 (12) 1909-1917; DOI: https://doi.org/10.2215/CJN.04830421
    Add to Selected Citations
  • Open Access
    BLISS in the Treatment of Lupus Nephritis
    Joshua M. Thurman
    CJASN June 2021, 16 (6) 969-971; DOI: https://doi.org/10.2215/CJN.17991120
    Add to Selected Citations
  • You have accessRestricted Access
    The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis
    Yonatan Peleg, Andrew S. Bomback and Jai Radhakrishnan
    CJASN July 2020, 15 (7) 1066-1072; DOI: https://doi.org/10.2215/CJN.13761119
    Add to Selected Citations
  • Open Access
    The Impact of Household Income on Kidney Care
    Stephen Weed
    CJASN March 2020, 15 (3) 299-300; DOI: https://doi.org/10.2215/CJN.00180120
    Add to Selected Citations
  • Open Access
    Social Determinants of Glomerular Disease
    Michelle M. O'Shaughnessy
    CJASN March 2020, 15 (3) 306-307; DOI: https://doi.org/10.2215/CJN.15051219
    Add to Selected Citations
  • Socioeconomic Position and Incidence of Glomerular Diseases
    Open Access
    Socioeconomic Position and Incidence of Glomerular Diseases
    Mark Canney, Dilshani Induruwage, Anahat Sahota, Cathal McCrory, Michelle A. Hladunewich, Jagbir Gill and Sean J. Barbour
    CJASN March 2020, 15 (3) 367-374; DOI: https://doi.org/10.2215/CJN.08060719
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire